INS and diabetes mellitus: We hypothesized that the new synthetic oral hypoglycemic would increase liver insulin sensitivity due to the activation of the ACE 2/Ang (1–7)/PI3K/AKT/mTOR axis on experimentally high-fat diet-induced diabetes in albino Wistar rats.